A basic science department examining cell-intrinsic and cell-extrinsic regulation of cell, developmental and cancer biology. READ ABOUT US.
CDCB WelcomesCDCB is pleased to welcome Sophia Bornstein, M.D., Ph.D., now as an Assistant Professor and Attending Physician with a primary appointment in Radiation Medicine, and a secondary appointment in CDCB. Dr. Bornstein officially started as an Assistant Professor and a director of the program in translational research in the Department of Radiation Medicine on October 1st. Her appointment is part of the wider Knight Cancer Institute initiative to create an environment of bedside to bench and back to bedside approach that combines patient care with research. This recruitment is transformational and represents an inflection point in the trajectory of our department as we build bridges with our clinical colleagues and departments. Welcome, Sophia!
CDCB in the news
Dr. Caroline Enns was elected to the American Association for the Advancement of Science (AAAS) this year for outstanding fundamental research discoveries on the biochemical, cell biological, and physiological mechanisms underlying iron homeostasis and its regulation. Read more.
OHSU cancer researcher aims to make cancer a manageable disease
About one in three Americans will be diagnosed with cancer in their lifetimes, and close to 600,000 will die as a result this year. Lisa Coussens hopes to dramatically reduce that number, making cancer a manageable disease instead of a deadly one. While traditional cancer research focuses on the malignant cells themselves, Coussens, a professor at the Knight Cancer Institute at the Oregon Health and Science University, is part of a new wave of biologists investigating the surrounding microenvironment. Read more.
OHSU researching new breast cancer drug
Women with the most aggressive form of breast cancer are getting some new hope from research done right here in Portland. Women with triple negative breast cancer don't usually respond to the most traditional therapies. The prognosis is also another five to eight years to live, but this new research is aiming at extending that. Read more.